The aim of this collaboration is the establishment of the clinical entity of WASF1-related neurodevelopmental disorder. For this aim, it is important to accumulate as much patient information as possible. Inclusion criteria is the patients who have WASF1 variants associated with dominant negative effects. Clinical manifestations of the patients are also needed. By this collaboration, more precise genotype-phenotype correlation would be confirmed.
WASF1